News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
12,652 Results
Type
Article (844)
Company Profile (3)
Press Release (11805)
Section
Business (3901)
Career Advice (20)
Deals (680)
Drug Delivery (1)
Drug Development (350)
FDA (285)
Job Trends (361)
News (5256)
Policy (335)
Tag
Academia (51)
Accelerated approval (1)
Allergies (1)
Alliances (1205)
Alzheimer's disease (6)
Antibody-drug conjugate (ADC) (5)
Approvals (287)
Artificial intelligence (8)
Autoimmune disease (1)
Automation (1)
Bankruptcy (11)
Best Places to Work (294)
Biosimilars (1)
Bladder cancer (3)
Breast cancer (9)
Cancer (39)
Cardiovascular disease (11)
Career advice (20)
CAR-T (1)
Cell therapy (6)
Cervical cancer (1)
Clinical research (297)
Collaboration (39)
Compensation (6)
COVID-19 (12)
CRISPR (1)
C-suite (6)
Cystic fibrosis (5)
Data (30)
Diabetes (6)
Diagnostics (225)
Drug discovery (4)
Drug pricing (1)
Earnings (1174)
Events (1353)
Executive appointments (14)
FDA (312)
Funding (30)
Gene editing (1)
Generative AI (1)
Gene therapy (4)
GLP-1 (7)
Government (56)
Guidances (4)
Healthcare (199)
Immunology and inflammation (2)
Immuno-oncology (2)
Infectious disease (15)
Influenza (1)
Intellectual property (4)
Interviews (3)
IPO (310)
Job creations (84)
Job search strategy (19)
Labor market (1)
Layoffs (4)
Legal (80)
Longevity (1)
Lung cancer (7)
Lymphoma (1)
Manufacturing (14)
MASH (2)
Medical device (422)
Medtech (423)
Mergers & acquisitions (382)
Metabolic disorders (10)
Multiple sclerosis (1)
NASH (3)
Neurodegenerative disease (4)
Neuroscience (13)
NextGen: Class of 2026 (128)
Non-profit (69)
Obesity (4)
Opinion (10)
Ovarian cancer (1)
Partnered (2)
Patents (3)
Patient recruitment (1)
People (1256)
Pharmaceutical (1)
Pharmacy benefit managers (1)
Phase 1 (97)
Phase 2 (129)
Phase 3 (99)
Pipeline (59)
Policy (1)
Postmarket research (10)
Preclinical (58)
Press Release (1)
Prostate cancer (2)
Radiopharmaceuticals (1)
Rare diseases (8)
Real estate (154)
Regulatory (224)
Reports (2)
Research institute (48)
Resumes & cover letters (1)
Schizophrenia (1)
Series A (8)
Series B (4)
Sponsored (1)
Startups (143)
Supply chain (1)
Tariffs (1)
Vaccines (4)
Venture capital (2)
Weight loss (2)
Women's health (2)
Date
Last 7 days (12)
Last 30 days (30)
Last 365 days (330)
2026 (34)
2025 (331)
2024 (495)
2023 (684)
2022 (1075)
2021 (1066)
2020 (1018)
2019 (987)
2018 (702)
2017 (746)
2016 (695)
2015 (736)
2014 (540)
2013 (416)
2012 (531)
2011 (522)
2010 (356)
Location
Africa (16)
Arizona (1)
Asia (504)
Australia (87)
California (138)
Canada (70)
China (3)
Colorado (3)
Delaware (1)
Europe (1582)
Florida (24)
Illinois (3)
India (1)
Iowa (1)
Japan (6)
Maryland (10)
Massachusetts (168)
Michigan (1)
Minnesota (3)
New Jersey (9)
New Mexico (1)
New York (65)
North Carolina (9)
Northern California (92)
Ohio (7)
Oregon (2)
Pennsylvania (5)
Rhode Island (2)
South America (27)
Southern California (25)
Texas (3)
United States (454)
Utah (1)
Washington State (7)
12,652 Results for "menarini silicon biosystems".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Menarini Silicon Biosystems announces PACE trial biomarker analysis results confirming clinical utility of CELLSEARCH® CTC enumeration to guide treatment decisions in a specific metastatic breast cancer subtype
December 23, 2025
·
4 min read
Pharm Country
Menarini Silicon Biosystems announces publication of the DETECT III trial results highlighting the potential clinical utility of HER2 testing in circulating tumor cells with CELLSEARCH
Menarini Silicon Biosystems, a pioneer of liquid biopsy technology, announced the publication, in the Journal of Clinical Chemistry, of the final results of the multicenter DETECT III clinical trial.
January 9, 2024
·
5 min read
Press Releases
Insilico Medicine Receives USD 5million Milestone Payment from Menarini Group Following First-in-Human (FIH) Achievement for MEN2501
February 4, 2026
·
4 min read
Pharm Country
New Menarini Silicon Biosystems partnership with Alivio Health expands patient access to CELLSEARCH® liquid biopsy tests
Menarini Silicon Biosystems, a pioneer of liquid biopsy and single cell technologies, announced its partnership with Alivio Health.
May 17, 2023
·
4 min read
Pharm Country
Menarini Silicon Biosystems announces new study results on use of CELLSEARCH® liquid biopsy for earlier detection of relapse and to help inform decisions on patient management in stage III Melanoma
Menarini Silicon Biosystems, a pioneer of liquid biopsy technology, announced today the publication, in the peer-reviewed journal Cancers, of the results of a clinical study on the utility of CTCs to detect disease relapse substantially earlier than what is currently possible with routine surveillance imaging, in patients with stage III melanoma.
October 3, 2023
·
5 min read
Pharm Country
Menarini Silicon Biosystems announces the launch of its new CELLSEARCH® CTC test with the DLL3 biomarker for small cell lung cancer
Menarini Silicon Biosystems (MSB), a pioneer in liquid biopsy and single cell technologies, announced today the availability of its new CELLSEARCH CTC lab service to detect expression of the Delta-Like Ligand 3 (DLL3) protein in tumor cells circulating in the bloodstream.
July 13, 2023
·
4 min read
Pharm Country
Menarini Silicon Biosystems new CELLSEARCH® data presented at AACR 2023 annual meeting highlights trailblazing contributions of liquid biopsies for cancer research
Menarini Silicon Biosystems (MSB), a pioneer of liquid biopsy and single cell technologies, announced today the data from two posters to be presented at the April 14-19, 2023 annual meeting of the American Association for Cancer Research (AACR).
April 13, 2023
·
4 min read
Press Releases
Menarini Group Announces New Data on ELZONRIS® (tagraxofusp-erzs) to be Presented at the 67th American Society of Hematology Annual Meeting and Exposition
November 24, 2025
·
8 min read
Press Releases
Menarini Group Presents Elacestrant (ORSERDU®) Phase 2 Combination Data in Patients with ER+, HER2- Metastatic Breast Cancer (mBC) at the 2025 San Antonio Breast Cancer Symposium
December 8, 2025
·
10 min read
BioMidwest
Menarini Silicon Biosystems and DIESSE announced strategic partnership to distribute CHORUS TRIO in North America
Menarini Silicon Biosystems Inc, a US company part of the Menarini Group and DIESSE Diagnostica Senese Società Benefit S.p.A. announced at the American Association for Clinical Chemistry Annual Scientific Meeting & Clinical Lab Expo that they have entered into a commercial agreement for the exclusive distribution of the CHORUS TRIO immunometric assay system in the United States of America.
July 26, 2022
·
3 min read
1 of 1,266
Next
